The development of HPLC-DAD method for determination of active pharmaceutical ingredient in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio) acetate substance
Open Access
- 1 March 2019
- journal article
- research article
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 32 (1) , 5-9
Abstract
Derivatives of 1,2,4-triazole are actively researched by scientists and synthetic pharmacologists. The last studies have shown that potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate with low toxicity series exhibits antioxidant and hepatoprotective properties. Therefore, the purpose of this work was to develop a method for determining the API in the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate substance using the method of high-performance liquid chromatography with diode array detection (HPLC-DAD). As a result of this work, it is shown that the developed method is specific and meets the requirements of linearity, accuracy and precision. The results of determining the contents of the API in real samples indicate that the method can be proposed to control the quality of the potassium 2-((4-amino-5-(morpholinomethyl)-4H-1,2,4-triazol-3-yl)thio)acetate substance.Keywords
This publication has 12 references indexed in Scilit:
- Drug Discovery and Development2018
- Process Development and Robust Control of Physical Attributes of an Amorphous Drug SubstanceJournal of Pharmaceutical Sciences, 2018
- Synthesis of some novel pyridine compounds containing bis‐1,2,4‐triazole/thiosemicarbazide moiety and investigation of their antioxidant properties, carbonic anhydrase, and acetylcholinesterase enzymes inhibition profilesJournal of Biochemical and Molecular Toxicology, 2017
- Synthesis, biological evaluation and molecular modeling study of new (1,2,4-triazole or 1,3,4-thiadiazole)-methylthio-derivatives of quinazolin-4(3 H )-one as DHFR inhibitorsBioorganic Chemistry, 2017
- Validated stability-indicating HPLC-DAD method for determination of the recently approved hepatitis C antiviral agent daclatasvirAnnales Pharmaceutiques Françaises, 2017
- Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing ScienceClinical Pharmacology & Therapeutics, 2017
- Development and validation of an isocratic HPLC method for simultaneous determination of quaternary mixtures of antihypertensive drugs in pharmaceutical formulationsActa Chromatographica, 2017
- Synthesis, physical and chemical properties of 2-((4-R-3-(morfolinomethylen)-4H-1,2,4-triazole-5-yl)thio)acetic acid saltsCurrent issues in pharmacy and medicine: science and practice, 2017
- The study of antimicrobial activity of 2-((4-R-3-(morpholinomethylene)-4H-1,2,4-triazole-5-yl)thio)acetic acid saltsZaporozhye Medical Journal, 2016
- Sample preparation in analysis of pharmaceuticalsTrAC Trends in Analytical Chemistry, 2007